OptimizeRx Sees Surge in Short Interest

Shares of the healthcare tech firm drop as short positions rise amid market volatility

Apr. 18, 2026 at 12:40am

Got story updates? Submit your updates here. ›

An abstract, cinematic close-up of intricate banking machinery and mechanisms, conveying the complex financial forces impacting OptimizeRx's stock.The rise in short positions targeting OptimizeRx reflects growing concerns about the healthcare tech firm's outlook amid broader market volatility.Hillsdale Today

OptimizeRx Corp. (NASDAQ:OPRX), a healthcare technology company that operates a digital health network, saw a significant increase in short interest during March, with short positions rising 25% to nearly 2 million shares. This comes as the stock has declined from a 52-week high amid broader market volatility.

Why it matters

The rise in short interest indicates growing bearish sentiment around OptimizeRx, which provides digital tools to facilitate communication between pharmaceutical companies, payers, and healthcare providers. This could signal concerns about the company's performance or outlook, potentially impacting its stock price and ability to raise capital.

The details

As of March 31st, there was short interest totaling 1,988,505 shares of OptimizeRx, up from 1,590,947 shares on March 15th. This represents about 11.2% of the company's outstanding shares. The average daily trading volume is 563,519 shares, meaning the current short interest represents about 3.5 days' worth of trading.

  • As of March 31st, 2026, short interest in OptimizeRx totaled 1,988,505 shares.
  • On March 15th, 2026, short interest was 1,590,947 shares.

The players

OptimizeRx Corp.

A healthcare technology company that operates a digital health network designed to facilitate communication between pharmaceutical manufacturers, payers and healthcare providers.

Got photos? Submit your photos here. ›

What’s next

Investors and analysts will be closely watching OptimizeRx's upcoming financial results and any updates on the company's business strategy to gauge whether the rise in short interest is warranted.

The takeaway

The surge in short interest in OptimizeRx's stock reflects growing skepticism about the healthcare tech firm's near-term prospects, potentially driven by broader market volatility. This could put pressure on the company's share price and access to capital, underscoring the need for OptimizeRx to demonstrate a clear path to sustainable growth.